TERNS PHARMACEUTICALS INC. - COMMON STOCK

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

02 4月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

20 3月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(C)(4)

26 2月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Provides Program Updates and Announces Participation at TD Cowen 45th Annual Healthcare Conference

25 2月 2025 08:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Appoints Andrew Gengos as Chief Financial Officer

24 2月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors

20 2月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

05 2月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

03 2月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

08 1月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

02 1月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia

03 12月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

02 12月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

18 11月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates

12 11月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences

06 11月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

07 10月 2024 16:05:00 条件 Nasdaq GlobeNewswire

Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

12 9月 2024 19:00:00 条件 Nasdaq GlobeNewswire

Terns Announces Pricing of Upsized $150.15 Million Public Offering

10 9月 2024 22:50:00 条件 Nasdaq GlobeNewswire

Terns Announces Proposed Public Offering

09 9月 2024 16:01:00 条件 Nasdaq GlobeNewswire

Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity

09 9月 2024 07:05:00 条件 Nasdaq GlobeNewswire